FDA’s approval of the first medical device of its kind to treat ADHD in children s being met with 'cautious optimism' by parents and advocates.
The U.S. Food and Drug Administration’s approval of the first medical device of its kind to treat ADHD in children between the ages of 7 and 12 years-old is being met with"cautious optimism" by parents and advocates.
In a clinical trial done over four weeks involving 62 children with moderate to severe ADHD, there was"statistically significant improvement" in reducing their symptoms. But some doctors are cautiously optimistic, urging more research before parents start buying these devices. The new Monarch eTNS device, however, is not without its own side effects including drowsiness, headaches, and an increased appetite.
"This is as close to a side effect free treatment device that you’re going to get," he said."So there’s very little downside risk to seeing if there’s a benefit."
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA OKs first medical device to treat ADHD in childrenThe first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK'd Friday by the US Food and Drug Administration. The device delivers a low-level electrical pulse to the parts of the brain.
Baca lebih lajut »
FDA signs off on first medical device for treating ADHD in childrenAs diagnosis rates of ADHD among children skyrocket, a new medical device for the treatment of ADHD could soon be hitting the market.
Baca lebih lajut »
Widely used pesticide linked to lower IQs, ADHD in children could soon be bannedGet breaking national and world news, broadcast video coverage, and exclusive interviews. Find the top news online at ABC news.
Baca lebih lajut »
Houston high school enforces parent dress code: 'You are your child's first teacher''We are preparing our children for the future and it begins here,' the school's principal said.
Baca lebih lajut »
Snap's 110% moonshot this year still isn't enough to get Wall Street rooting for itSnapchat parent company Snap is scheduled to report first-quarter earnings after the bell on Tuesday.
Baca lebih lajut »
Houston high school enforces parent dress code, bans pajamas and low-cut tops: 'You are your child's first teacher''We are preparing our children for the future and it begins here,' the school's principal said.
Baca lebih lajut »
Wing gets FAA approval in step toward drone deliveryWing, a part of Alphabet that began as a Google X project, has become the first drone-delivery company to receive a critical Federal Aviation Administration certification
Baca lebih lajut »
FDA OKs first medical device to treat ADHD in childrenThe first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK'd Friday by the US Food and Drug Administration. The device delivers a low-level electrical pulse to the parts of the brain.
Baca lebih lajut »
FDA signs off on first medical device for treating ADHD in childrenAs diagnosis rates of ADHD among children skyrocket, a new medical device for the treatment of ADHD could soon be hitting the market.
Baca lebih lajut »
Ketamine, once known for its club-enhancing effects, is now an FDA-approved antidepressant. Here's what it does to your brain.Ketamine, once known for its 'club enhancing' effects, is now an FDA approved antidepressant, hope for many with treatment-resistant depression.
Baca lebih lajut »